The efficacy of intravenous bolus Dexmedetomidine and mepridine on the treatment of shivering following general anesthesia

Phase 3

Recruiting

• Conditions: Shivering following general anesthesia.; Other complications of anesthesia; T88.5

• Registration Number: IRCT20150125020795N4
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with ASA grade one or two
Age range of 18 to 65 years
After surgery, the patient has grade 3 or 4 shivering anesthesia.

Exclusion Criteria

Patients under 18 or over 65 years
Previous sensitivity to pethidine or dexmedetomidine
Patient's low blood pressure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stop shivering. Timepoint: After surgery and the patient is discharged from anesthesia, shivering will be recorded within 15 minutes of treatment initiation and shivering time. Method of measurement: Observe and record the severity (shivering grade) and duration of shivering.

Secondary Outcome Measures

Name	Time	Method
Hemodynamic effects. Timepoint: After surgery and the patient is discharged from anesthesia, Patients with Grade 3 and 4 shivering, blood pressure and heart rate, oxygen saturation and axillary temperature will be measured every 5 minutes. Method of measurement: Blood pressure and heart rate measurement using a monitoring and oxygen saturation percentage using an pulseoximeter and axillary temperature using a digital thermometer.